Dec 05, 2023 / 06:00PM GMT
Todd Tushla -
Please welcome Neurocrine's Chief Executive Officer, Dr. Kevin Gorman.
Kevin C. Gorman - Neurocrine Biosciences, Inc. - CEO & Director
That was an introduction. Welcome, everyone. Thank you very much for coming here this afternoon. You're going to see very little of me because you guys hear enough from me, I think, over the years. And so we have an outstanding team and an outstanding agenda for today.
As far as that team goes, you're going to be able to see all of the senior management team is -- from Neurocrine is here. There are several that you've heard from many times before in our webcast, there's many more that this can be an opportunity for you to interact with. But even more important, I think, is that you're going to get an idea of the depth that we have at Neurocrine at least slightly get an understanding more of the depth we have at Neurocrine because we've brought our senior leaders within the company with us here who actually run the departments, run the programs that are so important to us.
So I really hope that you go
Neurocrine Biosciences Inc To Host Analyst Day Transcript
Feb 08, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers